Alignment Healthcare (NASDAQ:ALHC) confirmed that its president, Dawn Christine Maroney, sold 30,000 shares of common stock on April 15, 2026, for approximately $626,199. The sales occurred at prices ranging from $20.76 to $21.07 per share, around the stock's current trading level of $20.92.
After completing the sale, Maroney's direct stake in Alignment Healthcare stands at 1,028,813 shares. The transaction was disclosed amid a market backdrop in which the company's shares are trading roughly 80% above their 52-week low. InvestingPro data cited alongside the transaction indicates the shares remain undervalued compared with their Fair Value.
Investors also have a near-term corporate event to monitor: earnings are scheduled in 14 days. The article notes analysts are forecasting that Alignment Healthcare will return to profitability this year. For market participants seeking deeper analysis, a comprehensive Pro Research Report is available for ALHC.
Separately, Alignment Healthcare announced a secondary offering by an affiliate of General Atlantic, L.P., consisting of 13.2 million shares priced at $19.46 per share. The company stated it will not receive any proceeds from this sale. That offering is scheduled to close on March 4, 2026, subject to customary closing conditions.
Market reactions following the company’s fourth-quarter results remain generally favorable among some sell-side analysts. Raymond James reiterated a Strong Buy rating and set a $27.00 price target after what the firm described as an impressive fourth quarter. Alignment Healthcare reported a 25% increase in membership and a 44.4% rise in revenue year-over-year for the fourth quarter, outpacing expectations.
Piper Sandler likewise kept an Overweight rating and established a $30.00 price target after the company’s fourth-quarter 2025 results exceeded expectations. Both firms highlighted metrics tied to the company’s performance, calling out the medical benefit ratio and adjusted EBITDA as notable contributors to their constructive stances.
The sequence of events - an insider sale, a large secondary offering by a private equity affiliate, and imminent earnings - places several items on investors' near-term watchlists. The reported analyst optimism on membership growth, revenue acceleration, and margin metrics provides context for why some firms retain favorable ratings despite the additional share supply announced by a third party.